Literature DB >> 10465346

Detection of gene deletions in Chinese patients with Duchenne/Becker muscular dystrophy using CDNA probes and the polymerase chain reaction method.

L Yuge1, L Hui, X Bingdi.   

Abstract

One hundred thirty-eight patients with Duchenne/Becker muscular dystrophy (DMD/BMD) were screened with complete cDNA probes and the multiplex polymerase chain reaction (mPCR) amplification of 18 pairs of oligonucleotide primers. Eighty-six deletions and 4 duplications were detected, the deletion frequency being 62.3%. Eighty-two deletions were detected with the two sets of primers described by Chamberlain et al. and Beggs et al, which was 95.4% of deletions detected by complete cDNA probes. Consistent with the deletion locations described previously, the deletions of dystrophin gene in Chinese individuals are clustered mainly in two high-frequency deletion regions of exons 44-52 (68.6%) of 3' side of the gene central regions and exons 1-19 (26.7%) in the 5' side. The distribution of deletions in dystrophin gene is associated with the phenotype of DMD/BMD. In the 25 cases with in-frame deletions, 15 deletions located in the region of exons 2-47 were milder BMD and intermediate patients, as the location of deletions was not the important region of the dystrophin gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465346     DOI: 10.1016/s0024-3205(99)00316-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Assessing pathogenicity for novel mutation/sequence variants: the value of healthy older individuals.

Authors:  Mayana Zatz; Rita de Cassia M Pavanello; Naila Cristina V Lourenço; Antonia Cerqueira; Monize Lazar; Mariz Vainzof
Journal:  Neuromolecular Med       Date:  2012-06-16       Impact factor: 3.843

2.  Mutation spectrum analysis of Duchenne/Becker muscular dystrophy in 68 families in Kuwait: The era of personalized medicine.

Authors:  Fawziah Mohammed; Alaa Elshafey; Haya Al-Balool; Hayat Alaboud; Mohammed Al Ben Ali; Adel Baqer; Laila Bastaki
Journal:  PLoS One       Date:  2018-05-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.